D&B Business Directory
CHILTERN INTERNATIONAL LIMITED
Overview
For Chiltern International, going through a phase is not such a bad thing. Chiltern, a Covance company is now a Covance Clinical-Biotech and is part of the company's Covance Drug development business. A contract research organization (CRO), Chiltern provides a range collaborative services which include conducting thousands of clinical trials for a wide range of drugs, biologics, medical devices and diagnostics across all phases of development, involving ...
Read More
different study populations and across many therapeutic areas. It also provides clinical development, data and analysis, pharmacovigilance, strategic regulatory, and medical and scientific affairs. Chiltern operates in over 45 countries in Europe, the Americas, and the Asia-Pacific region. Chiltern has significant clinical development experience in industries including Biotech, Pharmaceuticals, Biosimilars and Biologics, and Medical Device and Diagnostics.
Read Less
David Cooper   See more contacts
?
?
Estimated

#
Actual
?
? ?
Contacts
Get in Touch with 3 Principals*
  • David Cooper
    Director
  • Contact 2
    ?
  • Contact 3
    ?
D&B Hoovers Logo

Dynamic search and list-building capabilities

Real-time trigger alerts

Comprehensive company profiles

Valuable research and technology reports

Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Stay on top of your Business Credit File
Get full access to view your D&B business credit file now for just $39/month!
View D&B Scores & Ratings